Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating induction FOLFOX with or without aflibercept followed by chemoradiation in high-risk locally advanced rectal cancer has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aflibercept (Aflibercept)
  • FOLFOX

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-05-03